Invention Grant
- Patent Title: Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
-
Application No.: US15281795Application Date: 2016-09-30
-
Publication No.: US10040840B2Publication Date: 2018-08-07
- Inventor: Laura D. J. Antipov , Shawdee Eshghi , Kristopher M. Kuchenbecker , Bjorn L. Millard , Matthew D. Onsum , Andrea D. Nickerson , Timothy R. Stowe , Yan Zhang
- Applicant: Silver Creek Pharmaceuticals, Inc.
- Applicant Address: US CA San Francisco
- Assignee: Silver Creek Pharmaceuticals, Inc.
- Current Assignee: Silver Creek Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Greenberg Traurig, LLP
- Agent Natalie Salem
- Main IPC: C07K14/65
- IPC: C07K14/65 ; C07K14/47 ; C07K14/765 ; A61K38/00
Abstract:
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
Public/Granted literature
- US20170096469A1 Bi-Specific Therapeutic Proteins for Tissue Repair Public/Granted day:2017-04-06
Information query
